Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Patients prefer laparoscopy to laparotomy

May 2006
Uterine cancer is the most common cancer of the female reproductive organs. The American Cancer Society estimates that there will be more than 41,000 cases diagnosed this year. Laparotomy, a surgical procedure in which an incision is made in the abdomen, has been the traditional treatment. However, it often causes wound complications, adhesion formation and long hospital stays. A study led by Alice B. Kornblith at Dana-Farber Cancer Institute in Boston found that patients treated by laparoscopy experience a better quality of life compared with those treated by laparotomy.

Laparoscopy involves inserting a slender tube through an incision made in the stomach so that organs of the pelvic area can be examined using small amounts of light. For a study presented in March at the Society of Gynecologic Oncologists’ 37th Annual Meeting on Women’s Cancer in Palm Springs, Calif., 782 patients were randomly assigned to laparoscopy or laparotomy in a clinical trial conducted by the Gynecologic Oncology Group.

All patients were given questionnaires about their quality of life after treatment. Six weeks after surgery, laparoscopy patients reported an overall higher quality of life in terms of pain, physical functioning, resumption of normal activities and a shorter hospital stay, than those who underwent laparotomy. However, after six months, the two groups did not report significant differences in these areas, except for body image, which remained significantly better for laparoscopy patients.

The researchers believe that, because laparoscopy resulted in fewer high-grade (grade 2 and above) postoperative complications and shorter hospital stays and because there was a significant improvement in quality of life six weeks after surgery, it should be considered as a procedure option for patients with uterine cancer.

BiophotonicsFrom The Clinic

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.